FSC 6505 × LEVONORGESTREL AND ETHINYL ESTRA
LEVONORGESTREL AND ETHINYL ESTRA
6505-01-224-0176
Open for bid
No open solicitations on record for this NSN right now.
Can you win it?
Restricted — approved sources only, based on the latest AMSC/AMC on record.
What it is — can you make it?
Dimensions, the FLIS specification requirements, and the manufacturer part numbers already qualified against this NSN.
Specifications
From the federal catalog (DLA FLIS / PUB LOG) — what your part has to meet. Cited specification documents can be looked up in ASSIST Quick Search ↗, DoD's public spec repository — copy the document number in.
| Requirement | Value |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH AKJA | MILLIGRAMS ETHINYL ESTRADIOL ACTIVE INGREDIENT 0.040 AND MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT 0.050 AND MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT 0.075 AND MILLIGRAMS LEVONORGESTREL ACTIVE INGREDIENT 0.125 |
| PRIMARY CONTAINER TYPE CQCT | DISPENSER, PLASTIC COMPACT |
| PRIMARY CONTAINER CONTENT QUANTITY CRLK | TABLETS 28.000 |
| TOTAL PRIMARY CONTAINER QUANTITY CSCW | 6 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY CXCY | LEVONORGESTREL AND ETHINYL ESTRADIOL TABLETS (TRIVORA) 168S |
| SPECIAL FEATURES FEAT | 28 TABLETS PER EACH CYCLE COMPACT CONTAINING IN SEQUENCE: 6 TABLETS LEVONORGESTREL 0.050 MG AND ETHINYL ESTRADIOL 0.030 MG FOLLOWED BY 5 TABLETS LEVONORGESTREL 0.075 MG AND ETHINYL ESTRADIOL 0.040 MG FOLLOWED BY 10 TABLETS LEVONORGESTREL 0.125 MG AND ETHINYL ESTRADIOL 0.030 MG FOLLOWED BY 7 TABLETS OF INERT INGREDIENTS. STORE AT 20 - 25 C (68 - 77 F). (SEE USP CONTROLLED ROOM TEMPERATURE). |
| MEDICAL DESIGNATION AND GRADE MDES | UNITED STATES PHARMACOPEIA |
| SUPPLEMENTARY FEATURES SUPP | CONTAINS 6 CYCLES OF 28 TABLETS; MEDSEP ITEM FOR DOD,BERLEX LABS |
Manufacturer part numbers
Commercial part numbers cross-referenced to this NSN in the federal catalog — the parts that have been accepted as satisfying this stock number, and who makes them.
| Part number | CAGE | Manufacturer |
|---|---|---|
| ENPRESSE 6 X 28 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
| MYZLIRA 6 X 28 | 0ET99 | GENERICS BIDCO I, LLC DBA PAR PHARMACEUTICAL |
| NDC00555-9047-58 | 3V8D7 | TEVA PHARMACEUTICALS USA, INC. |
| NDC51862-0510-06 | 4HH72 | MAYNE PHARMA COMMERCIAL LLC |
| NDC52544-0291-28 | 6LMB8 | ACTAVIS PHARMA, INC. |
| TRIVORA 6 X 28 | 6LMB8 | ACTAVIS PHARMA, INC. |
What it pays — so you can quote
The government's own price and demand record for this NSN — what past awards cleared at, so you know where to land your quote.
Price history
What the government paid per unit
Fewer than two priced purchases on record — see the table below.
Purchase history
No priced purchases on record for this NSN yet.
Related contract actions
Contract action totals, not unit prices — obligation amounts from USAspending for related awards, shown for context only. These do not appear on the price chart above.
No related contract actions on record.
Demand history
Every solicitation we've indexed for this NSN, open and closed — 1 on record. Closed RFQs (expired, cancelled, or awarded) stay here as a record of past demand; they never get removed.
| Solicitation | Issued | Closes / closed | Qty | Status | |
|---|---|---|---|---|---|
| SPE2DP-26-T-4515 | Aug 6, 2026 | Aug 11, 2026 | 2 | Expired | View at DIBBS → |
Open RFQs on DIBBS → DIBBS award history ↗
About this data
- Unit prices: DLA DIBBS award records — every row links to its government record.
- AMSC: latest observed value from DIBBS solicitation history.
- Contract action totals: USAspending, context only.
- Full methodology →